Prestige Consumer Healthcare to Release Fiscal 2026 First Quarter Earnings Results

Rhea-AI Summary

Prestige Consumer Healthcare (NYSE:PBH) has scheduled its fiscal 2026 first quarter earnings release for Thursday, August 7, 2025, before market opening. The company will host a conference call and webcast at 8:30 a.m. ET on the same day to discuss the results.

Investors can access the live webcast through the company's Investor Relations webpage at prestigeconsumerhealthcare.com. For phone participation, registration is required to receive dial-in details and a unique pin. A replay of the conference call will be available for approximately one week on the company's IR page.

News Market Reaction – PBH

-1.66%

1 alert

-1.66% News Effect

On the day this news was published, PBH declined 1.66%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

TARRYTOWN, N.Y., July 15, 2025 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2026 first quarter earnings release on Thursday, August 7, 2025 before the opening of the market. The Company will host a conference call to discuss the results that same morning at 8:30 a.m. ET.

To participate in the live Internet webcast of the conference call, it can be accessed from the Investor Relations page of www.prestigeconsumerhealthcare.com. To participate in the conference call via phone, participants may register for the call here to receive dial-in details and a unique pin. While not required, it is recommended to join 10 minutes prior to the event start.

A conference call replay will be available for approximately one week following completion of the live call and can be accessed on the Company’s Investor Relations page.

About Prestige Consumer Healthcare Inc.

Prestige Consumer Healthcare markets, sells, manufactures and distributes consumer healthcare products to retail outlets throughout the U.S. and Canada, Australia, and in certain other international markets. The Company’s diverse portfolio of brands include Monistat^® and Summer’s Eve^® women's health products, BC^® and Goody's^® pain relievers, Clear Eyes^® and TheraTears® eye care products, DenTek^® specialty oral care products, Dramamine^® motion sickness treatments, Fleet^® enemas and glycerin suppositories, Chloraseptic^® and Luden's^® sore throat treatments and drops, Compound W^® wart treatments, Little Remedies^® pediatric over-the-counter products, Boudreaux’s Butt Paste^® diaper rash ointments, Nix^® lice treatment, Debrox^® earwax remover, Gaviscon^® antacid in Canada, and Hydralyte^® rehydration products and the Fess^® line of nasal and sinus care products in Australia. Visit the Company's website at www.prestigeconsumerhealthcare.com.

Investor Relations Contact
Phil Terpolilli, CFA, 914-524-6819
irinquiries@prestigebrands.com

FAQ

When will Prestige Consumer Healthcare (PBH) release its Q1 2026 earnings?

Prestige Consumer Healthcare will release its Q1 2026 earnings on Thursday, August 7, 2025 before the market opens.

How can investors access PBH's Q1 2026 earnings conference call?

Investors can access the conference call through a live webcast on prestigeconsumerhealthcare.com's Investor Relations page or via phone by registering to receive dial-in details.

What time is Prestige Consumer Healthcare's Q1 2026 earnings call?

The earnings conference call is scheduled for 8:30 a.m. ET on August 7, 2025.

How long will PBH's Q1 2026 earnings call replay be available?

The conference call replay will be available for approximately one week following the live call on the company's Investor Relations page.